Feature

HHS to allow insurers’ workaround on 2019 prices


 


“It’s not an easy question,” Mr. Azar said.

The fact that the federal government ended up effectively making the payments aggravated many Republicans, and there have been rumors over the past several months that HHS might require the premium increases to be applied across all plans, boosting costs for all buyers in the individual market.

Seema Verma, the administrator of the Centers for Medicare & Medicaid Services, told reporters in April that the department was examining the possibility.

Apparently that will not happen, at least not for plan year 2019.

Kaiser Health News is a nonprofit national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation that is not affiliated with Kaiser Permanente.

Pages

Recommended Reading

FDA’s Gottlieb floats ideas on Medicare drug coverage
MDedge Rheumatology
Legalization of marijuana debate moving away from medical need
MDedge Rheumatology
Specialty practices hire more physician assistants and nurse practitioners
MDedge Rheumatology
Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Rheumatology
MDedge Daily News: Keeping patients summer safe
MDedge Rheumatology
Peer mentorship, groups help combat burnout in female physicians
MDedge Rheumatology
Effects of psoriatic arthritis not just physical
MDedge Rheumatology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Rheumatology
AMA: Opioid prescriptions down since 2013
MDedge Rheumatology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Rheumatology